CD93 and chronic myelogenous leukemia, BCR-ABL1 positive: After 16 weeks, there was a statistically significant increase in engraftment of human CD45+CD33+ cells within the BM of mice transplanted with Lin−CD34+CD93+ cells from four independent CP-CML samples (CML351 p = 0.015; CML393 p < 0.05; CML391 p < 0.0001; CML385 p = 0.0119) (Fig. 3e).